+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatology CRO Market Size, Share & Trends Analysis Report By Type (Preclinical, Clinical), By Service Type (Laboratory, Regulatory/Medical Affairs), By Region (North America, Asia Pacific), And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 175 Pages
  • June 2023
  • Region: Global
  • Grand View Research
  • ID: 5457617
Description Jump to:
The global dermatology CRO market size is expected to reach USD 8,057.9 million by 2030, registering a CAGR of 6.8% over the forecast period, according to this report. Rising influx of contract research organizations (CROs) to mitigate the disease burden associated with dermatological conditions is a key driver for this market. Moreover, the rising demand for topical dermatological medications, such as anti-infective, anti-inflammatory agents, local anesthetics, emollients, and cleansers, to cure acne are major factors driving the market growth. High demand for speedy diagnosis, an increase in the prevalence of skin cancer and other skin problems, and increased awareness regarding skin diseases are major factors boosting the market growth.

An increase in cases of skin disease across the globe is expected to propel the market growth in the forecast period. Atopic dermatitis is one of the most common inflammatory skin diseases, affecting around 5-10% of individuals in the U.S. Around one in three individuals in the country with atopic dermatitis have moderate-to-severe disease. Moreover, skin cancer is the most common cancer in the U.S. According to the American Academy of Dermatology, around 1 in 5 individuals would develop skin cancer in their lifetime. In addition, it is estimated that around 9500 individuals in the country are diagnosed with skin cancer every day. The COVID-19 pandemic significantly impacted the market.

Clinical trials in numerous therapeutic fields, including dermatology, were impacted by the COVID-19 pandemic. Several clinical trials were temporarily delayed or halted, impacting the timelines and progress of research studies. This disruption is expected to affect the growth and revenue of dermatology CROs, as their services are closely tied to clinical trial activities. Furthermore, patent expiration in the dermatology industry and growing investment in R&D programs are key factors anticipated to drive market growth in the coming years. For instance, in February 2022, Recipharm acquired CDMO Arranta Bio to expand its mRNA biologics offerings in the U.S. This acquisition is expected to improve the company's capabilities in developing medications in the area of cancer, psoriasis, infectious diseases, and other diseases.

Dermatology CRO Market Report Highlights

  • Based on type, the clinical segment accounted for the largest revenue share of 76.10% in 2022. This is attributed to the globalization of clinical trials, technological advancements, and an increase in demand for dermatology CROs to conduct clinical trials
  • Based on service type, the regulatory/medical affairs segment is expected to show a significant market share in the forecast period. Increasing demand to obtain approval for new products and differences in drug regulations globally are some of the major factors driving the segment growth
  • Asia Pacific captured the largest revenue share of over 43.29% in 2022. This is due to the diversity in population, high prevalence of skin disorders, improving regulatory framework, and, the ease with which patients may be recruited and retained
  • A post-covid surge in clinical trials provided a lucrative opportunity for CROs to enter the dermatology space. For instance, in January 2022, Vial started providing dermatology outsourcing services via its arm Vial Dermatology CRO. Wherein, they partnered with 35 dermatology clinics in the U.S. to provide faster clinical trials

Table of Contents

Chapter 1. Research Methodology And Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.1.2. Type
1.1.3. Service Type
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Dermatology CRO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing adoption of advanced technologies
3.2.1.2. Growing interest to look more appealing
3.2.1.3. Increasing outsourcing of R&D activities
3.2.1.4. Favorable environment for clinical trials in developing countries
3.2.2. Market Restraint Analysis
3.2.2.1. Quality issues of CRO services
3.2.2.2. Intellectual property rights issues
3.3. Dermatology CRO Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Dermatology CRO Market: Type Estimates & Trend Analysis
4.1. Dermatology CRO Market, By Type: Segment Dashboard
4.2. Dermatology CRO Market, By Type: Movement Analysis
4.3. Dermatology CRO Market Estimates & Forecasts, By Type, 2018 - 2030
4.3.1. Drug Discovery
4.3.1.1. Drug Discovery Market, 2018 to 2030 (USD Million)
4.3.1.2. Target Validation
4.3.1.2.1. Target Validation Market, 2018 to 2030 (USD Million)
4.3.1.3. Lead Identification
4.3.1.3.1. Lead Identification Market, 2018 to 2030 (USD Million)
4.3.1.4. Lead Optimization
4.3.1.4.1. Lead Optimization Market, 2018 to 2030 (USD Million)
4.3.2. Preclinical
4.3.2.1. Preclinical Market, 2018 to 2030 (USD Million)
4.3.3. Clinical
4.3.3.1. Clinical Market, 2018 to 2030 (USD Million)
4.3.3.2. Phase I
4.3.3.2.1. Phase I Market, 2018 to 2030 (USD Million)
4.3.3.3. Phase II
4.3.3.3.1. Phase II Market, 2018 to 2030 (USD Million)
4.3.3.4. Phase III
4.3.3.4.1. Phase III Market, 2018 to 2030 (USD Million)
4.3.3.5. Phase IV
4.3.3.5.1. Phase IV Market, 2018 to 2030 (USD Million)
Chapter 5. Dermatology CRO Market: Service Type Estimates & Trend Analysis
5.1. Dermatology CRO Market, By Service Type: Segment Dashboard
5.2. Dermatology CRO Market, By Service Type: Movement Analysis
5.3. Dermatology CRO Market Estimates & Forecasts, By Service Type, 2018 - 2030
5.3.1. Project Management/Clinical Supply Management
5.3.1.1. Project Management/Clinical Supply Management Market, 2018 to 2030 (USD Million)
5.3.2. Data Management
5.3.2.1. Data Management Market, 2018 to 2030 (USD Million)
5.3.3. Regulatory/Medical Affairs
5.3.3.1. Regulatory/Medical Affairs Market, 2018 to 2030 (USD Million)
5.3.4. Medical Writing
5.3.4.1. Medical Writing Market, 2018 to 2030 (USD Million)
5.3.5. Clinical Monitoring
5.3.5.1. Clinical Monitoring Market, 2018 to 2030 (USD Million)
5.3.6. Quality Management/ Assurance
5.3.6.1. Quality Management/ Assurance Market, 2018 to 2030 (USD Million)
5.3.7. Bio-statistics
5.3.7.1. Bio-statistics Market, 2018 to 2030 (USD Million)
5.3.8. Investigator Payments
5.3.8.1. Investigator Payments Market, 2018 to 2030 (USD Million)
5.3.9. Laboratory
5.3.9.1. Laboratory Market, 2018 to 2030 (USD Million)
5.3.10. Patient and site Recruitment
5.3.10.1. Patient and site Recruitment Market, 2018 to 2030 (USD Million)
5.3.11. Laboratory
5.3.11.1. Laboratory Market, 2018 to 2030 (USD Million)
5.3.12. Technology
5.3.12.1. Technology Market, 2018 to 2030 (USD Million)
5.3.13. Others
5.3.13.1. Others Market, 2018 to 2030 (USD Million)
Chapter 6. Dermatology CRO Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2022 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. North America
6.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
6.5. Europe
6.5.1. UK
6.5.1.1. Key Country Dynamics
6.5.1.2. Competitive Scenario
6.5.1.3. Regulatory Framework
6.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
6.5.2. Germany
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
6.5.3. France
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
6.5.4. Italy
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
6.5.5. Spain
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
6.5.6. Denmark
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
6.5.7. Sweden
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
6.5.8. Norway
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key Country Dynamics
6.6.1.2. Competitive Scenario
6.6.1.3. Regulatory Framework
6.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
6.6.2. India
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
6.6.4. South Korea
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
6.6.6. Thailand
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key Country Dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory Framework
6.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
6.7.2. Mexico
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
6.7.4. Colombia
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
6.7.5. Chile
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030
6.8. MEA
6.8.1. South Africa
6.8.1.1. Key Country Dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory Framework
6.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
6.8.2. Saudi Arabia
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
6.8.3. UAE
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
6.8.4. Israel
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. Israel Market Estimates and Forecasts, 2018 - 2030
6.8.5. Iran
6.8.5.1. Key Country Dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory Framework
6.8.5.4. Iran Market Estimates and Forecasts, 2018 - 2030
6.8.6. Kuwait
6.8.6.1. Key Country Dynamics
6.8.6.2. Competitive Scenario
6.8.6.3. Regulatory Framework
6.8.6.4. Kuwait Market Estimates and Forecasts, 2018 - 2030
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.1.1. Innovators
7.1.2. Market Leaders
7.1.3. Emerging Players
7.1.4. Company Market Share Analysis, 2022
7.2. Company Profiles
7.2.1. IQVIA, Inc.
7.2.1.1. Company Overview
7.2.1.2. Financial Performance
7.2.1.3. Service Benchmarking
7.2.1.4. Strategic Initiatives
7.2.2. Labcorp Drug Development
7.2.2.1. Company Overview
7.2.2.2. Financial Performance
7.2.2.3. Service Benchmarking
7.2.2.4. Strategic Initiatives
7.2.3. Aragen Life Sciences Ltd
7.2.3.1. Company Overview
7.2.3.2. Financial Performance
7.2.3.3. Service Benchmarking
7.2.3.4. Strategic Initiatives
7.2.4. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
7.2.4.1. Company Overview
7.2.4.2. Financial Performance
7.2.4.3. Service Benchmarking
7.2.4.4. Strategic Initiatives
7.2.5. Parexel International Corporation
7.2.5.1. Company Overview
7.2.5.2. Financial Performance
7.2.5.3. Service Benchmarking
7.2.5.4. Strategic Initiatives
7.2.6. Charles River Laboratories
7.2.6.1. Company Overview
7.2.6.2. Financial Performance
7.2.6.3. Service Benchmarking
7.2.6.4. Strategic Initiatives
7.2.7. Icon, Plc
7.2.7.1. Company Overview
7.2.7.2. Financial Performance
7.2.7.3. Service Benchmarking
7.2.7.4. Strategic Initiatives
7.2.8. Medidata
7.2.8.1. Company Overview
7.2.8.2. Financial Performance
7.2.8.3. Service Benchmarking
7.2.8.4. Strategic Initiatives.
7.2.9. Syneos Health
7.2.9.1. Company Overview
7.2.9.2. Financial Performance
7.2.9.3. Service Benchmarking
7.2.9.4. Strategic Initiatives
7.2.10. S Pharmaron
7.2.10.1. Company Overview
7.2.10.2. Financial Performance
7.2.10.3. Service Benchmarking
7.2.10.4. Strategic Initiatives
7.2.11. Wuxi Apptec
7.2.11.1. Company Overview
7.2.11.2. Financial Performance
7.2.11.3. Service Benchmarking
7.2.11.4. Strategic Initiatives
7.2.12. Medpace
7.2.12.1. Company Overview
7.2.12.2. Financial Performance
7.2.12.3. Service Benchmarking
7.2.12.4. Strategic Initiatives
7.2.12.5. CTI Clinical Trial & Consulting
7.2.13. CTI Clinical Trial & Consulting
7.2.13.1. Company Overview
7.2.13.2. Financial Performance
7.2.13.3. Service Benchmarking
7.2.13.4. Strategic Initiatives
7.2.14. Bioskin
7.2.14.1. Company Overview
7.2.14.2. Financial Performance
7.2.14.3. Service Benchmarking
7.2.14.4. Strategic Initiatives
7.2.15. Proinnovera GmbH
7.2.15.1. Company Overview
7.2.15.2. Financial Performance
7.2.15.3. Service Benchmarking
7.2.15.4. Strategic Initiatives
7.2.16. Biorasi, LLC
7.2.16.1. Company Overview
7.2.16.2. Financial Performance
7.2.16.3. Service Benchmarking
7.2.16.4. Strategic Initiatives
7.2.17. Javara
7.2.17.1. Company Overview
7.2.17.2. Financial Performance
7.2.17.3. Service Benchmarking
7.2.17.4. Strategic Initiatives
7.2.18. TFS
7.2.18.1. Company Overview
7.2.18.2. Financial Performance
7.2.18.3. Service Benchmarking
7.2.18.4. Strategic Initiatives
List of Tables
Table 1: List of secondary sources
Table 2: List of Abbreviations
Table 3: North America Dermatology CRO Market, By Region, 2018-2030 (USD Million)
Table 4: North America Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 5: North America Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 6: U.S. Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 7: U.S. Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 8: Canada Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 9: Canada Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 10: Europe Dermatology CRO Market, By Region, 2018-2030 (USD Million)
Table 11: Europe Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 12: Europe Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 13: UK Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 14: UK Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 15: Germany Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 16: Germany Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 17: France Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 18: France Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 19: Italy Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 20: Italy Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 21: Spain Dermatology CRO Market, By Test Type, 2018-2030 (USD Million)
Table 22: Spain Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 23: Denmark Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 24: Denmark Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 25: Sweden Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 26: Sweden Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 27: Norway Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 28: Norway Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 29: Asia Pacific Dermatology CRO Market, By Region, 2018-2030 (USD Million)
Table 30: Asia Pacific Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 31: Asia Pacific Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 32: China Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 33: China Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 34: Japan Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 35: Japan Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 36: India Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 37: India Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 38: Australia Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 39: Australia Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 40: South Korea Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 41: South Korea Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 42: Thailand Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 43: Thailand Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 44: Latin America Dermatology CRO Market, By Region, 2018-2030 (USD Million)
Table 45: Latin America Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 46: Latin America Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 47: Brazil Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 48: Brazil Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 49: Mexico Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 50: Mexico Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 51: Argentina Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 52: Argentina Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 53: Colombia Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 54: Colombia Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 55: Chile Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 56: Chile Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 57: Middle East And Africa Dermatology CRO Market, By Region, 2018-2030 (USD Million)
Table 58: Middle East And Africa Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 59: Middle East And Africa Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 60: South Africa Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 61: South Africa Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 62: Saudi Arabia Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 63: Saudi Arabia Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 64: UAE Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 65: UAE Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 66: Iran Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 67: Iran Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
Table 68: Israel Dermatology CRO Market, By Type, 2018-2030 (USD Million)
Table 69: Israel Dermatology CRO Market, By Service Type, 2018-2030 (USD Million)
List of Figures
Fig. 1: Market research process
Fig. 2: Information Procurement
Fig. 3: Primary research pattern
Fig. 4: Market research approaches
Fig. 5: Value chain based sizing & forecasting
Fig. 6: QFD modelling for market share assessment
Fig. 7: Market segmentation & scope
Fig. 8: Dermatology CRO market outlook, 2018-2030
Fig. 9: Market trends & outlook
Fig. 10: Penetration & growth prospect mapping by service, 2022
Fig. 11: Market driver relevance analysis (Current & future impact)
Fig. 12: Market restraint relevance analysis (Current & future impact)
Fig. 13: SWOT Analysis, By factor (political & legal, economic and technological)
Fig. 14: Porter’s five forces analysis
Fig. 16: Global dermatology CRO market: Type movement analysis
Fig. 17: Drug discovery market 2018-2030 (USD Million)
Fig. 18: Target validation market 2018-2030 (USD Million)
Fig. 19: Lead identification market 2018-2030 (USD Million)
Fig. 20: Lead optimization market 2018-2030 (USD Million)
Fig. 21: Preclinical market 2018-2030 (USD Million)
Fig. 22: Clinical market 2018-2030 (USD Million)
Fig. 23: Phase I market 2018-2030 (USD Million)
Fig. 24: Phase II market 2018-2030 (USD Million)
Fig. 25: Phase III market 2018-2030 (USD Million)
Fig. 26: Phase IV market 2018-2030 (USD Million)
Fig. 27: Global dermatology CRO market: Service Type movement analysis
Fig. 28: Project management/clinical supply management market 2018-2030 (USD Million)
Fig. 29: Data management market 2018-2030 (USD Million)
Fig. 30: Regulatory/medical affairs market 2018-2030 (USD Million)
Fig. 31: Medical writing market 2018-2030 (USD Million)
Fig. 32: Clinical monitoring market 2018-2030 (USD Million)
Fig. 33: Quality management/ assurance market 2018-2030 (USD Million)
Fig. 34: Bio-statistics market 2018-2030 (USD Million)
Fig. 35: Investigator payments market 2018-2030 (USD Million)
Fig. 36: Laboratory market 2018-2030 (USD Million)
Fig. 37: Patient and site recruitment market 2018-2030 (USD Million)
Fig. 38: Technology market 2018-2030 (USD Million)
Fig. 39: Others market 2018-2030 (USD Million)
Fig. 40: Regional market place: Key takeaway
Fig. 41: Dermatology CRO regional outlook, 2022 & 2030
Fig. 42: North America dermatology CRO market, 2018-2030 (USD Million)
Fig. 43: U.S. dermatology CRO market, 2018-2030 (USD Million)
Fig. 44: Canada dermatology CRO market, 2018-2030 (USD Million)
Fig. 45: Europe dermatology CRO market, 2018-2030 (USD Million)
Fig. 46: Germany dermatology CRO market, 2018-2030 (USD Million)
Fig. 47: France dermatology CRO market, 2018-2030 (USD Million)
Fig. 48: UK dermatology CRO market, 2018-2030 (USD Million)
Fig. 49: Spain dermatology CRO market, 2018-2030 (USD Million)
Fig. 50: Italy dermatology CRO market, 2018-2030 (USD Million)
Fig. 51: Sweden dermatology CRO market, 2018-2030 (USD Million)
Fig. 52: Denmark dermatology CRO market, 2018-2030 (USD Million)
Fig. 53: Norway dermatology CRO market, 2018-2030 (USD Million)
Fig. 54: Asia Pacific dermatology CRO market, 2018-2030 (USD Million)
Fig. 55: China dermatology CRO market, 2018-2030 (USD Million)
Fig. 56: Japan dermatology CRO market, 2018-2030 (USD Million)
Fig. 57: India dermatology CRO market, 2018-2030 (USD Million)
Fig. 58: Australia dermatology CRO market, 2018-2030 (USD Million)
Fig. 59: South Korea dermatology CRO market, 2018-2030 (USD Million)
Fig. 59: Thailand dermatology CRO market, 2018-2030 (USD Million)
Fig. 60: Latin America dermatology CRO market, 2018-2030 (USD Million)
Fig. 61: Brazil dermatology CRO market, 2018-2030 (USD Million)
Fig. 62: Mexico dermatology CRO market, 2018-2030 (USD Million)
Fig. 63: Argentina dermatology CRO market, 2018-2030 (USD Million)
Fig. 64: Colombia dermatology CRO market, 2018-2030 (USD Million)
Fig. 65: Chile dermatology CRO market, 2018-2030 (USD Million)
Fig. 66: Middle East & Africa Dermatology CRO Market, 2018-2030 (USD Million)
Fig. 67: South Africa Dermatology CRO Market, 2018-2030 (USD Million)
Fig. 68: Saudi Arabia Dermatology CRO Market, 2018-2030 (USD Million)
Fig. 69: UAE Dermatology CRO Market, 2018-2030 (USD Million)
Fig. 70: Israel Arabia Dermatology CRO Market, 2018-2030 (USD Million)
Fig. 71: Iran Dermatology CRO Market, 2018-2030 (USD Million)
Fig. 72: Kuwait Dermatology CRO Market, 2018-2030 (USD Million)

Companies Mentioned

  • IQVIA, Inc.
  • Labcorp Drug Development
  • Aragen Life Sciences Ltd
  • Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
  • Parexel International Corporation
  • Charles River Laboratories
  • Icon, Plc
  • Medidata
  • Syneos Health
  • S Pharmaron
  • Wuxi Apptec
  • Medpace
  • CTI Clinical Trial & Consulting
  • Bioskin
  • Proinnovera GmbH
  • Biorasi, LLC
  • Javara
  • TFS

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages175
PublishedJune 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 4737.7 Million
Forecasted Market Value ( USD ) by 2030 $ 8057.9 Million
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Preclinical CRO Market by Services, Application, End-User - Global Forecast 2025-2030 - Product Image

Preclinical CRO Market by Services, Application, End-User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
In Vivo CRO Market Size, Share & Trends Analysis Report by Model Type (Rodent Based, Non-rodent Based), Modality (Small Molecule, Large Molecule), Indication, GLP Type (Non GLP, GLP Toxicology), Region, and Segment Forecasts, 2024-2030 - Product Image

In Vivo CRO Market Size, Share & Trends Analysis Report by Model Type (Rodent Based, Non-rodent Based), Modality (Small Molecule, Large Molecule), Indication, GLP Type (Non GLP, GLP Toxicology), Region, and Segment Forecasts, 2024-2030

  • Report
  • 257 Pages
  • Global
From
Pharmaceutical CRO Market Size, Share & Trends Analysis Report by Type (Drug Discovery, Pre-Clinical, Clinical), Molecule Type (Small Molecules, Large Molecules), Service, Therapeutic Areas, Region, and Segment Forecasts, 2025-2030 - Product Image

Pharmaceutical CRO Market Size, Share & Trends Analysis Report by Type (Drug Discovery, Pre-Clinical, Clinical), Molecule Type (Small Molecules, Large Molecules), Service, Therapeutic Areas, Region, and Segment Forecasts, 2025-2030

  • Report
  • 231 Pages
  • Global
From
Contract Research Organization (CROs) Services Market by Type (Early Phase, Clinical, Lab, Consulting, Data Management), Therapeutic Area (Cancer, Infectious Disease, Neurology, Dermatology, Immunology, Hematology, Vaccines, CGT) - Forecast to 2029 - Product Image

Contract Research Organization (CROs) Services Market by Type (Early Phase, Clinical, Lab, Consulting, Data Management), Therapeutic Area (Cancer, Infectious Disease, Neurology, Dermatology, Immunology, Hematology, Vaccines, CGT) - Forecast to 2029

  • Report
  • 483 Pages
  • Global
From
Biopharmaceutical CMO & CRO Market by Source, Service Type, Product, Scale of Operation, Therapeutic Applications - Global Forecast 2025-2030 - Product Image

Biopharmaceutical CMO & CRO Market by Source, Service Type, Product, Scale of Operation, Therapeutic Applications - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From

About the Dermatology CRO Market

The Dermatology CRO market is a subset of the biotechnology industry that focuses on providing clinical research services for dermatology-related products. These services include clinical trial design, protocol development, data management, regulatory affairs, and medical writing. Dermatology CROs are typically contracted by pharmaceutical and biotechnology companies to conduct clinical trials for dermatology-related products, such as drugs, medical devices, and cosmetics. Dermatology CROs are typically staffed with experienced professionals who specialize in the design and execution of clinical trials for dermatology-related products. These professionals are often highly trained in the areas of clinical research, regulatory affairs, and medical writing. Additionally, they are often well-versed in the latest technologies and techniques used in the dermatology field. Some of the companies in the Dermatology CRO market include Parexel, ICON, Syneos Health, PPD, and Quintiles. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.